经典和下一代大麻素配体的开发和治疗潜力
Verónica Muñoz-Canales1, Bellinda Benhamú1, Mar Martín-Fontecha2
1Departamento de Química Orgánica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Plaza de las Ciencias 2, Madrid E-28040, Spain.
Pharmacological research
|November 5, 2025
概括
本综述探讨了大麻素受体连接体的发展,从天然化合物到合成调节器. 它强调了理解内源性大麻素系统 (ECS) 和其治疗潜力的进展.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 药物发现 药物发现 药物发现
背景情况:
- 内源性大麻素系统 (ECS) 对生理过程至关重要.
- 大麻素受体 (CB1,CB2) 是治疗干预的关键点.
- 对于ECS来说,配体开发是一个快速发展的领域.
研究的目的:
- 提供有关大麻素受体配体发展的最新视角.
- 审查天然和合成连接物,包括orthosteric和allosteric调节剂.
- 讨论ECS向药物开发的临床应用和未来方向.
主要方法:
- 关于大麻素受体配体研究的文献综述.
- 对天然配体 (植物性大麻素,内分泌大麻素) 和合成化合物的分析.
- 探索全性,偏向性,共价性连接体和化学探针.
主要成果:
- 从古典到非古典大麻素和新型调节剂的演变.
- 对于受体可视化的成像和化学蛋白质组学的进步.
- 通过精细调制器来减少副作用的机会的识别.
结论:
- 大麻素配体研究提供了对受体信号的精细控制.
- 新兴的策略和临床试验显示出基于ECS的治疗方法的前景.
- 需要进一步的研究来克服ECS向药物开发的挑战.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
758
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
758
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
658
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
658
Ligand-gated Ion Channels
13.9K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
13.9K
Opioid Receptors: Overview
4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K
Drug-Receptor Interaction: Agonist
3.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.8K


